Boehringer takes a neuroscience approach to obesity with latest deal

Damian Garde

Ingelheim is pairing up with a small California biotech to explore the role circuits in the nervous system play in , scouting for drug targets that could spur weight loss.

FierceBiotech News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS